F048 Big Rashes in Little Patients
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Rashes with inflammatory and infectious etiologies often have different clinical appearances, time courses, and associated features in infants and children than in adults. This session provides an update on new and under-recognized cutaneous presentations of pediatric infections, reactive eruptions, and inflammatory dermatoses. Case-based scenarios will be utilized to provide clinical pearls, highlight the differential diagnosis, and illustrate strategies for evaluation and management. Topics will range from common but oftentimes frustrating inflammatory conditions such as atopic dermatitis and psoriasis to recent developments in contact dermatitis, infectious rashes, and connective tissue diseases.
LEARNING OBJECTIVES
Recognize the spectrum of cutaneous manifestations of inflammatory disorders and infections in pediatric patients.
Identify distinctive cutaneous features and extracutaneous associations of inflammatory dermatoses, reactive eruptions, and infections in children.
Formulate appropriate management plans for pediatric rashes.
SCHEDULE
8:30 PM
Update on the management of severe atopic dermatitis in pediatric patients
Karen Chernoff, MD, FAAD
8:55 PM
Q & A
Karen Chernoff, MD, FAAD
9:00 PM
Hot topics in pediatric infectious skin conditions
Elizabeth A. Swanson, MD, FAAD
9:25 PM
Q & A
Elizabeth A. Swanson, MD, FAAD
9:30 PM
Contact dermatitis in children: challenging cases and mimickers
JiaDe Yu, MD, FAAD
9:55 PM
Q & A
JiaDe Yu, MD, FAAD
10:00 PM
Childhood rashes: what's new and what's true
Julie V. Schaffer, MD, FAAD
10:25 PM
Q & A
Julie V. Schaffer, MD, FAAD
SPEAKERS
Karen Chernoff, MD, FAAD
Julie V. Schaffer, MD, FAAD
Elizabeth A. Swanson, MD, FAAD
JiaDe Yu, MD, FAAD
SPEAKER DISCLOSURES
Karen Chernoff, MD, FAAD
No financial relationships exist with ineligible companies.
Julie V. Schaffer, MD, FAAD
American Board of Dermatology – Employee(Salary); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights);
Elizabeth A. Swanson, MD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Alphyn Biologics – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Castle Biosciences – Advisory Board(Honoraria); Dermavant Sciences – Advisory Board(Honoraria); Dermavant Sciences, Inc. – Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Speaker(Honoraria); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); Incyte – Advisory Board(Honoraria); Incyte Corporation – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Speaker(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Novan – Advisory Board(Honoraria); Novartis – Speaker(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Othro Dermatologics – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria), Speaker(Honoraria);
JiaDe Yu, MD, FAAD
American Contact Dermatitis Society – Board of Directors(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Dermavant Sciences – Speaker/Faculty Education(Honoraria); Incyte – Advisory Board(Honoraria); L'Oreal – Consultant (1099 relationship)(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Speaker(Honoraria); Leo Pharma – Advisory Board(Honoraria); National Eczema Association – Consultant(Fees), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria);